Enanta Pharmaceuticals Inc (ENTA)

Enanta Pharmaceuticals Inc Azioni (ENTA) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	5.27% 17.05	18.00	18.93	18.89	17.80
Operating Expenses	5.80% 49.82	52.89	49.96	55.60	57.25
Interest Income/Expense	25.52% 2.563	3.441	3.151	1.997	-
Benefits Costs and Expenses	6.65% 48.57	52.03	48.45	53.74	55.41
Costs And Expenses	5.80% 49.82	52.89	49.96	55.60	57.25
Depreciation and Amortization	3.27% 0.621	0.642	0.669	0.651	0.54
Operating Income/Loss	6.08% -32.77	-34.89	-31.03	-36.71	-39.45
Nonoperating Income/Loss	45.39% 1.246	0.857	1.513	1.869	1.837
Income/Loss From Continuing Operations Before Tax	7.37% -31.52	-34.03	-29.52	-34.84	-37.61
Income Tax Expense/Benefit	41.64% -0.363	-0.622	-1.41	4.221	0.044
Income/Loss From Continuing Operations After Tax	6.74% -31.16	-33.41	-28.11	-39.06	-37.66
Net Income/Loss	6.74% -31.16	-33.41	-28.11	-39.06	-37.66
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.37% 21.17	21.09	-20.92	21.05	21.04
Diluted Average Shares	0.37% 21.17	21.09	-20.92	21.05	21.04
Basic Earnings Per Share	6.96% -1.47	-1.58	-1.33	-1.86	-1.79
Diluted Earnings Per Share	6.96% -1.47	-1.58	-1.33	-1.86	-1.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-